Nomura Ignites IKS Health: 'Buy' Call & ₹2000 Target Hint at 28% Surge!

Overview

Global brokerage Nomura has initiated coverage on Inventurus Knowledge Solutions Ltd (IKS Health) with a 'Buy' rating and a ₹2,000 price target, signalling a potential 28% stock increase. Nomura cited strong growth in the US healthcare outsourcing market and IKS Health's key client relationships as reasons for its optimistic outlook, forecasting significant EPS growth.